Cookson Peirce & CO Inc United Therapeutics Corp Transaction History

Cookson Peirce & CO Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 31, 2023	SELL	$205.95 - $280.43 $74,142 - $100,954	-360 Reduced 6.93%	4,836 $1.34 Million
Q3 2022 Nov 08, 2022	BUY	$203.3 - $244.17 $8,741 - $10,499	43 Added 0.83%	5,196 $1.09 Million
Q2 2022 Jul 20, 2022	BUY	$174.81 - $241.14 $900,795 - $1.24 Million	5,153 New	5,153 $1.21 Million
Q1 2022 May 03, 2022	SELL	$166.16 - $213.96 $611,468 - $787,372	-3,680 Closed	0 $0
Q4 2021 Jan 31, 2022	BUY	$184.32 - $216.08 $47,554 - $55,748	258 Added 7.54%	3,680 $795,000
Q3 2021 Nov 04, 2021	BUY	$179.86 - $214.88 $49,821 - $59,521	277 Added 8.81%	3,422 $631,000
Q2 2021 Aug 03, 2021	BUY	$170.47 - $211.93 $34,434 - $42,809	202 Added 6.86%	3,145 $564,000
Q1 2021 May 11, 2021	BUY	$153.94 - $174.85 $453,045 - $514,583	2,943 New	2,943 $492,000

669

42.8M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $17B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Cookson Peirce & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Cookson Peirce & CO Inc with notifications on news.